Grigory G. Borisenko - Net Worth and Insider Trading

Grigory G. Borisenko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Grigory G. Borisenko owns 1 companies in total, including Xenetic Biosciences Inc (XBIO) .

Click here to see the complete history of Grigory G. Borisenko’s form 4 insider trades.

Insider Ownership Summary of Grigory G. Borisenko

Ticker Comapny Transaction Date Type of Owner
XBIO Xenetic Biosciences Inc 2019-09-26 director

Grigory G. Borisenko Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Grigory G. Borisenko Ownership Network

Ownership Network List of Grigory G. Borisenko

No Data

Ownership Network Relation of Grigory G. Borisenko

Insider Network Chart

Grigory G. Borisenko Owned Company Details

What does Xenetic Biosciences Inc do?

Who are the key executives at Xenetic Biosciences Inc?

Grigory G. Borisenko is the director of Xenetic Biosciences Inc. Other key executives at Xenetic Biosciences Inc include Chief Financial Officer James F Parslow , Chief Scientific Officer Curtis Lockshin , and 10 percent owner Pharmsynthez Pjsc .

Xenetic Biosciences Inc (XBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xenetic Biosciences Inc (XBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xenetic Biosciences Inc (XBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xenetic Biosciences Inc (XBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xenetic Biosciences Inc Insider Transactions

No Available Data

Grigory G. Borisenko Mailing Address

Above is the net worth, insider trading, and ownership report for Grigory G. Borisenko. You might contact Grigory G. Borisenko via mailing address: 40 Speen Street, Suite 102, Framingham Ma 01701.

Discussions on Grigory G. Borisenko

No discussions yet.